Skip to main content
Medicamen Biotech Ltd. logo

Medicamen Biotech Ltd. — Investor Relations & Filings

Ticker · MEDICAMEQ ISIN · INE646B01010 LEI · 894500T0ULD27B7W4Y03 BSE.NS Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2023-09-27 AGM Information
Country IN India
Listing BSE.NS MEDICAMEQ

About Medicamen Biotech Ltd.

https://www.medicamen.com/

Medicamen Biotech Ltd. specializes in the research, development, and manufacturing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities compliant with international quality standards, including WHO-GMP. Its product portfolio encompasses various therapeutic segments such as oncology, cardiology, central nervous system, and anti-infectives, delivered through dosage forms like tablets, capsules, and liquid orals. A significant strategic focus is placed on its specialized oncology division, which develops complex generic formulations. The company serves global markets, leveraging its research and development capabilities to provide high-quality healthcare solutions. Its operations are supported by dedicated R&D centers focused on formulation development and process chemistry.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled as the 'Summary of proceedings of the 30th Annual General Meeting (AGM)' of Medicamen Biotech Limited held on 27th September 2023. It details the conduct of the AGM, including the chairman's address, voting procedures, resolutions considered (such as adoption of audited financial statements, dividend declaration, director appointments, and auditor remuneration), and the conclusion of the meeting. The document does not contain the full financial statements or detailed financial performance data but rather summarizes the meeting's proceedings and outcomes. It also references compliance with SEBI Listing Regulations and Companies Act provisions related to AGMs. Given these characteristics, the document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting, including summaries of proceedings and voting outcomes. The document is not a full Annual Report (10-K), nor is it a Declaration of Voting Results (DVA) since it summarizes the meeting proceedings rather than just voting results. Therefore, the appropriate classification is AGM-R with high confidence.
2023-09-27 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a short notice regarding the publication of the Notice of the 30th Annual General Meeting (AGM) in newspapers. It references the regulatory compliance under SEBI Listing Obligations and Disclosure Requirements. The document does not contain the AGM materials themselves but announces the publication of the AGM notice. The length is only 1229 characters, indicating it is an announcement rather than the full AGM information or report. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement related to the AGM notice, but since the notice itself is a meeting notice, the best fitting category is AGM Information (AGM-R) because it relates directly to the AGM notice publication. Confidence is high due to clear references to AGM notice publication and regulatory citations.
2023-09-04 English
Book Closure
Annual Report Classification · 100% confidence The document contains detailed content typical of an Annual Report, including sections such as Corporate Overview, Statutory Reports, Financial Statements, Management Discussion and Analysis, Corporate Governance Report, and detailed descriptions of company operations, R&D, manufacturing facilities, and strategic outlook. It references the financial year 2022-23 and includes comprehensive information about the company's business, strategy, and financial data. The document is lengthy (15,000 characters) and contains substantive financial and operational data, not merely an announcement or a brief notice. Therefore, it fits the definition of an Annual Report (10-K).
2023-09-02 English
Statement of deviation(s) or variation(s) under Reg. 32
Capital/Financing Update Classification · 95% confidence The document is a statement submitted under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, concerning deviations or variations in the utilization of funds raised through a preferential issue. It includes details about the amount raised, the quarter ended (June 30, 2023), and confirms no deviation in fund utilization. The document is an update on capital usage related to fundraising activities, not a full financial report or audit. It is a regulatory compliance filing specifically about capital/financing updates. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 4225 characters, which is sufficient to contain substantive information about the capital usage deviation statement, not just an announcement or certification.
2023-08-23 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter ended June 30, 2023. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30 & 47, which pertain to disclosure of financial results. The document includes an extract of unaudited financial results, including total income, net profit/loss, and earnings per share for the quarter. The presence of detailed financial data for a quarter and the term 'unaudited financial results' indicate this is a quarterly financial report. The document is about the results themselves, not just an announcement of their publication, and it contains substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-08-09 English
Financial Result Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication titled 'Outcome of Board Meeting' dated 08.08.2023, addressed to stock exchanges. It announces the approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023, by the Board of Directors. It also mentions the inclusion of Limited Review Reports on these results. The document is short (1753 characters) and serves as an announcement of the financial results and related reports rather than containing the full financial statements or detailed analysis itself. According to the 'Menu vs Meal' rule, such announcements of results and reports are classified as Regulatory Filings (RNS) rather than Interim/Quarterly Reports (IR) because the actual financial data and detailed report are not fully included here but are referenced as available elsewhere.
2023-08-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.